Christof K.
- Country
- Germany
- Department
- Clinic for Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology
Research Overview
- Evaluation of Melphalan-Based Chemotherapy Regimens in Low and Intermediate Risk Neuroblastoma: A Multicenter, Prospective Study
- Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
- Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors
Data & Insights
Has run more than one trial at 105 of 197 partner sites.
Specializations
Pediatric Oncology Focus
This investigator specializes in treating various forms of childhood cancers, with particular emphasis on neuroblastoma, germ cell tumors, and medulloblastoma. Their clinical research extends to innovative approaches in managing high-risk pediatric tumors and rare childhood cancers.
- Neurological Tumors
- Germ Cell Malignancies
- Brain Cancer Management
Hematologic Malignancies
The investigator demonstrates significant expertise in treating blood-related cancers, particularly focusing on acute lymphoblastic leukemia and B-cell lymphomas. Their work includes specialized treatment protocols for relapsed cases and high-risk disease variants.
- Lymphoblastic Lymphoma
- Leukemia Treatment
- Rituximab-Based Therapies
Targeted Therapeutics
Their research encompasses novel therapeutic approaches including immunotherapy and molecular targeted treatments. The investigator works with innovative agents such as avapritinib and nivolumab in treating various pediatric solid tumors.
- KIT/PDGFRA Signaling Pathways
- EBV-Associated Cancers
- Precision Medicine Applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.